These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2252337)

  • 41. Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin receptors and the acute attack of migraine.
    Goadsby PJ
    Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Headache: classification, mechanism and principles of therapy, with particular reference to migraine.
    Lance JW
    Recenti Prog Med; 1989 Dec; 80(12):673-80. PubMed ID: 2516913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug development.
    Goadsby PJ
    Drugs R D; 1999 Dec; 2(6):361-74. PubMed ID: 10763443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Plosker GL; McTavish D
    Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathophysiological and pharmacological basis of current drug treatment of migraine headache.
    Reddy DS
    Expert Rev Clin Pharmacol; 2013 May; 6(3):271-88. PubMed ID: 23656340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
    Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
    Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-Hydroxytryptamine and its putative aetiological involvement in migraine.
    Lance JW; Lambert GA; Goadsby PJ; Zagami AS
    Cephalalgia; 1989; 9 Suppl 9():7-13. PubMed ID: 2661013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging treatments in headache.
    Diener HC; Gendolla A; Jüptner M; Kaube H; Limmroth V
    Eur Neurol; 1997; 38(3):167-74. PubMed ID: 9363828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New vistas on 5-HT receptors and migraine.
    Peroutka SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):191-7. PubMed ID: 1871321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in migraine management.
    Cady RK; Shealy CN
    J Fam Pract; 1993 Jan; 36(1):85-91. PubMed ID: 8380430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
    Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
    Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets.
    Welch KM
    Neurol Sci; 2003 May; 24 Suppl 2():S149-53. PubMed ID: 12811616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics of migraine patients.
    Rasmussen BK
    Cephalalgia; 1996 Feb; 16(1):4. PubMed ID: 8825692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.